Stock Events

Antilia Group 

$0
2
+$0+0% Thursday 20:00

Statistics

Day High
0
Day Low
0
52W High
0
52W Low
0
Volume
250
Avg. Volume
0
Mkt Cap
429
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

31OctExpected
Q3 2017
Q1 2018
Q2 2018
Q3 2018
Q1 2019
Q2 2019
Q3 2019
-0
-0
-0
0
Expected EPS
0
Actual EPS
-0.0018

People Also Follow

This list is based on the watchlists of people on Stock Events who follow AGGG. It's not an investment recommendation.
Alphabet
75255
GOOGL
Apple
65568
AAPL
Microsoft
61046
MSFT
Amazon
56526
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Bioceres Crop Solutions
BIOX
Mkt Cap644.65M
Direct competitor in genomic sequencing technologies, similar market segments.
CRISPR Therapeutics
CRSP
Mkt Cap4.06B
Offers competing CRISPR technology for gene editing, targeting similar therapeutic areas.
Illumina
ILMN
Mkt Cap20.93B
Provides genomic sequencing solutions that compete with Antilia's products.
Intellia Therapeutics
NTLA
Mkt Cap2.28B
Involved in gene editing, directly competing in the therapeutic applications market.
Editas Medicine
EDIT
Mkt Cap308.46M
Focuses on gene editing technology, competing in the same biotech innovation sector.
Pacific Biosciences of California
PACB
Mkt Cap373.36M
Produces long-read sequencing platforms, a direct competitor in the genomic analysis market.
Regeneron Pharmaceuticals
REGN
Mkt Cap130.59B
Biopharmaceutical company with overlapping drug development programs in genetics.
Vertex Pharmaceuticals
VRTX
Mkt Cap127.99B
Engages in drug discovery and development, competing in genetic disorder treatments.
Alnylam Pharmaceuticals
ALNY
Mkt Cap33.72B
Specializes in RNAi therapeutics, competing in genetic medicine and drug development.

About

Specialty Stores
Retail Trade
Antilia Group, Corp. engages in the development of applications (apps) and games. It develops Android and iOS apps and games. The company was founded in 2016 and is based in Sosua, Dominican Republic. Antilia Group, Corp. operates as a subsidiary of Greenwich Holdings Ltd.
Show more...
CEO
Country
US
ISIN
US03704T1097

Listings

US
AGGG